혈액투석 및 복막투석 시장 규모, 점유율 및 동향 분석 : 유형별, 제품별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Hemodialysis And Peritoneal Dialysis Market Size, Share & Trends Analysis By Type (Hemodialysis, Peritoneal Dialysis), By Product (Device, Consumables, Service), By End-use (Home-based, Hospital-based), By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,401,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,813,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,637,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

혈액투석 및 복막투석 시장의 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면 세계 혈액투석 및 복막투석 시장 규모는 예측 기간 동안 연평균 복합 성장률(CAGR) 9.1%를 기록하며 2030년까지 1,858억 8,000만 달러에 달할 것으로 예상됩니다.

노인 인구의 현저한 증가와 함께 신장 질환의 발병률이 증가함에 따라 혈액투석 및 복막투석에 대한 세계 시장 수요를 촉진하고 있습니다. 또한, 신제품 개발을 위한 자금 조달 증가는 시장에 유리한 시나리오를 가져다 줄 것입니다.

최근 몇 년동안 코로나19의 대유행은 입원 환자 급증과 국내 곳곳의 감염 핫스팟과 관련이 있습니다. 이 전염병은 만성 신장 질환(CKD), 당뇨병 및 고혈압과 같은 동반 질환의 높은 유병률로 인해 전 세계적으로 신장 대체 요법(RRT)에 대한 수요 증가로 이어졌습니다. 이 기간 동안 투석기에 대한 수요가 크게 증가했으며, 미국 신장학회(American Society of Nephrology) 저널에 게재된 연구에 따르면 2020년 봄 뉴욕시에서 발생한 AKI 사례 관리에 필요한 투석기 수요는 기준치보다 279% 더 많았다고 합니다.

또한, 말기신부전증(ESRD) 유병률 증가도 시장 성장에 힘을 보태고 있습니다. 예를 들어, USRDS에 따르면 2020년에는 ESRD 환자가 2.5% 증가할 것으로 예상되며, 2010년부터 2019년까지 ESRD 치료를 받은 신규 환자 130,400명이 등록되어 14.84% 증가했다고 합니다.

혈액투석 및 복막투석 시장 보고서 하이라이트

• 유형별로는 혈액투석 분야가 2023년 82.71%의 점유율로 금액 기준으로 시장을 장악하고 예측 기간 동안 6.0%의 최고 CAGR로 성장할 것으로 예상되며, ESRD 환자 증가와 신장 질환을 앓고 있는 노인 인구의 급증은 이 부문의 성장을 가속하는 주요 요인입니다.
• 제품별로는 서비스 부문이 2023년 56.61%의 점유율로 시장을 장악했습니다. 투석 서비스를 제공하는 제공업체 수 증가와 선진국의 최신 기술 보급이 이 분야의 성장에 기여하고 있습니다.
• 최종 용도별로는 병원 기반 부문이 2023년 76.75%의 점유율을 차지하며 시장을 장악하고 있는데, 이는 독립적인 투석 센터 설립에 집중하는 기업이 증가하고 있고, 환자들이 투석 센터에서의 치료를 선호하는 경향이 강해졌기 때문입니다.
• 북미는 2023년 38.25%로 혈액투석 및 복막투석 시장에서 가장 높은 매출 점유율을 차지했습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 혈액투석 및 복막투석 시장 변수, 동향 및 범위

• 시장 계통 전망
  • 상위 시장 전망
  • 관련/부수 시장 전망
• 보급과 성장 전망 매핑
• 업계 밸류체인 분석
  • 상환 프레임워크
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 혈액투석 및 복막투석 시장 분석 툴
  • 업계 분석 - Porter의 Five Forces 분석
  • PESTEL 분석
  • 주요 거래와 전략적 제휴 분석
  • 시장 진출 전략

제4장 혈액투석 및 복막투석 시장 : 유형 추정·동향 분석

• 정의와 범위
  • 혈액투석
  • 복막투석
• 유형 시장 점유율, 2023년 및 2030년
• 부문 대시보드
• 유형별 혈액투석 및 복막투석 시장 전망
• 이하 시장 규모, 예측 및 동향 분석, 2018-2030년
  • 혈액투석
  • 복막투석

제5장 혈액투석 및 복막투석 시장 : 제품 추정·동향 분석

• 정의와 범위
  • 디바이스
  • 소모품
  • 서비스
• 제품 시장 점유율, 2023년 & 2030년
• 부문 대시보드
• 제품별 혈액투석 및 복막투석 시장 전망
• 이하 시장 규모, 예측 및 동향 분석, 2018-2030년
  • 디바이스
  • 소모품
  • 서비스

제6장 혈액투석 및 복막투석 시장 : 최종 용도 추정·동향 분석

• 정의와 범위
  • 홈 기반
  • 병원 기반
• 최종 용도 시장 점유율, 2023년 및 2030년
• 부문 대시보드
• 최종 용도별 혈액투석 및 복막투석 시장 전망
• 이하 시장 규모, 예측 및 동향 분석, 2018-2030년
  • 홈 기반
  • 병원 기반

제7장 혈액투석 및 복막투석 시장 : 지역 추정·동향 분석

• 지역 시장 점유율 분석, 2023년 및 2030년
• 지역 시장 대시보드
• 세계의 지역 시장 스냅숏
• 지역 시장 점유율과 주요 기업, 2023년
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카
• 시장 제품, 예측 및 동향 분석, 2018-2030년
• 북미
  • 시장 추산·예측, 2018-2030년
  • 미국
  • 캐나다
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 인도
  • 중국
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제8장 경쟁 구도

• 주요 시장 진출기업의 최근 동향과 영향 분석
• 회사/경쟁사 분류
  • 이노베이터
• 벤더 구도
  • 주요 유통업체와 채널 파트너 리스트
  • 주요 고객
  • 주요 기업 점유율 분석, 2023년
  • BD
  • Baxter
  • B. Braun SE
  • Medtronic
  • Fresenius Medical Care AG
  • DaVita
  • Asahi Kasei Medical Co., Ltd.
  • Nipro Corp.
  • Nikkiso Co., Ltd.
  • Cantel Medical

LSH

영문 목차

영문목차

Hemodialysis And Peritoneal Dialysis Market Growth & Trends:

The global hemodialysis and peritoneal dialysis market size is expected to reach USD 185.88 billion by 2030, registering a CAGR of 9.1% during the forecast period, according to a new report by Grand View Research, Inc. Increasing incidence of renal diseases, alongside the noteworthy growth in geriatric population has fueled the market demand for hemodialysis and peritoneal dialysis globally. Moreover, growing funding for the development of new products will provide a lucrative scenario for the market.

Over the recent past, the COVID-19 pandemic has been associated with surges in hospitalization and infection hotspots around the country. The pandemic led to a growth in demand for Renal Replacement Therapy (RRT) globally, owing to higher prevalence of comorbid conditions, such as Chronic Kidney Diseases (CKD), diabetes, and hypertension. The demand for dialysis machines surged significantly during this period. As per a research study published in American Society of Nephrology, the demand for dialysis machines required to manage cases of AKI amplified by 279% over baseline during the spring of 2020 in New York City.

Moreover, the rising prevalence of End-stage Renal Disease (ESRD) is likely to propel the market. For instance, according to USRDS, in 2020, there was an increase of 2.5% of people suffering from ESRD. A total of 130,400 new patients were registered who were treated for ESRD which accounted increase of 14.84% of people suffering from ESRD from 2010-2019.

Hemodialysis And Peritoneal Dialysis Market Report Highlights:

• Based on type, hemodialysis segment dominated the market in terms of value with a share of 82.71% in 2023 and is expected to grow at the highest CAGR of 6.0% during the forecast period. Rising number of ESRD patients, surge in geriatric population suffering from kidney diseases, are significant factors driving the segment growth.
• Based on product, service segment dominated the market in 2023 with a share of 56.61%. Growing number of providers offering dialysis services coupled with the higher penetration of latest technology in the developed countries, is contributing to the segment growth.
• In end-use scope, hospital-based segment dominated the market with a share of 76.75% in 2023, owing to increased focus of players in establishing independent dialysis centers, and growing preference of patients to opt for treatment in in-center dialysis.
• North America dominated the hemodialysis and peritoneal dialysis market with the highest revenue share of 38.25% in 2023, owing to the presence of key participants, and high awareness about advanced dialysis devices among healthcare professionals & patients.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Type
  • 1.1.2. Product
  • 1.1.3. End-useEnd use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Product outlook
  • 2.2.3. End-use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Hemodialysis And Peritoneal Dialysis Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Industry Value Chain Analysis
  • 3.3.1. Reimbursement framework
• 3.4. Market Dynamics
  • 3.4.1. Market Driver Analysis
    • 3.4.1.1. Increasing prevalence of acute kidney injury (AKI) and associated chronic kidney diseases
    • 3.4.1.2. Increasing incidence and prevalence of ESRD
    • 3.4.1.3. Introduction to technologically advanced products
    • 3.4.1.4. Growing geriatric population
    • 3.4.1.5. Increase in number of diabetes patient
  • 3.4.2. Market Restraint Analysis
    • 3.4.2.1. Risk and complications associated with dialysis
    • 3.4.2.2. Issues with product approval and Commercialization
• 3.5. Hemodialysis And Peritoneal Dialysis Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's
    • 3.5.1.1. Supplier power
    • 3.5.1.2. Buyer power
    • 3.5.1.3. Substitution threat
    • 3.5.1.4. Threat of new entrant
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTEL Analysis
    • 3.5.2.1. Political landscape
    • 3.5.2.2. Technological landscape
    • 3.5.2.3. Economic landscape
  • 3.5.3. Major Deals & Strategic Alliances Analysis
  • 3.5.4. Market Entry Strategies

Chapter 4. Hemodialysis And Peritoneal Dialysis Market: Type Estimates & Trend Analysis

• 4.1. Definitions and Scope
  • 4.1.1. Hemodialysis
  • 4.1.2. Peritoneal Dialysis
• 4.2. Type Market Share, 2023 & 2030
• 4.3. Segment Dashboard
• 4.4. Hemodialysis And Peritoneal Dialysis Market by Type Outlook
• 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5.1. Hemodialysis
    • 4.5.1.1. Hemodialysis market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.2. Conventional
    • 4.5.1.2.1. Conventional market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.3. Short Daily Hemodialysis
    • 4.5.1.3.1. Short daily Hemodialysis market estimates and Forecast 2018 to 2030 (USD Million)
    • 4.5.1.4. Nocturnal Hemodialysis
    • 4.5.1.4.1. Nocturnal Hemodialysis Market Estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.2. Peritoneal Dialysis
    • 4.5.2.1. Peritoneal dialysis market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.2. Continuous Ambulatory Peritoneal Dialysis (CAPD)
    • 4.5.2.2.1. Continuous ambulatory peritoneal dialysis (CAPD) market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.3. Automated Peritoneal Dialysis (APD)
    • 4.5.2.3.1. Automated peritoneal dialysis (APD) market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Hemodialysis And Peritoneal Dialysis Market: Product Estimates & Trend Analysis

• 5.1. Definitions and Scope
  • 5.1.1. Device
  • 5.1.2. Consumables
  • 5.1.3. Service
• 5.2. Product Market Share, 2023 & 2030
• 5.3. Segment Dashboard
• 5.4. Hemodialysis And Peritoneal Dialysis Market by Product Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5.1. Device
    • 5.5.1.1. Device market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.2. Machine
    • 5.5.1.2.1. Machine market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.3. Dialyzers
    • 5.5.1.3.1. Dialyzers Market Estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.4. Water Treatment System
    • 5.5.1.4.1. Water treatment system market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.5. Others
    • 5.5.1.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.2. Consumables
    • 5.5.2.1. Consumables market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.2. Bloodlines
    • 5.5.2.2.1. Bloodlines market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.3. Concentrates
    • 5.5.2.3.1. Concentrates market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.4. Catheters
    • 5.5.2.4.1. Catheters Market Estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.5. Others
    • 5.5.2.5.1. Others market Estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.3. Service
    • 5.5.3.1. Service market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Hemodialysis And Peritoneal Dialysis Market: End-use Estimates & Trend Analysis

• 6.1. Definitions and Scope
  • 6.1.1. Home-Based
  • 6.1.2. Hospital-Based
• 6.2. End-use Market Share, 2023 & 2030
• 6.3. Segment Dashboard
• 6.4. Hemodialysis And Peritoneal Dialysis Market by End-use Outlook
• 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5.1. Home-Based
    • 6.5.1.1. Home-based market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.2. Hospital-Based
    • 6.5.2.1. Hospital-based market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Hemodialysis And Peritoneal Dialysis Market: Regional Estimates & Trend Analysis

• 7.1. Regional market share analysis, 2023 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Regional Market Share and Leading Players, 2023
  • 7.4.1. North America
  • 7.4.2. Europe
  • 7.4.3. Asia Pacific
  • 7.4.4. Latin America
  • 7.4.5. Middle East and Africa
• 7.5. Market Product, & Forecasts and Trend Analysis, 2018 to 2030
• 7.6. North America
  • 7.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.6.2. U.S.
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
  • 7.6.3. Canada
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. Canada market estimates and forecasts, 2018 - 2030
• 7.7. Europe
  • 7.7.1. UK
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Competitive scenario
    • 7.7.1.3. Regulatory framework
    • 7.7.1.4. Reimbursement scenario
    • 7.7.1.5. UK market estimates and forecasts, 2018 - 2030
  • 7.7.2. Germany
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Germany market estimates and forecasts, 2018 - 2030
  • 7.7.3. France
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. France market estimates and forecasts, 2018 - 2030
  • 7.7.4. Italy
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. Italy market estimates and forecasts, 2018 - 2030
  • 7.7.5. Spain
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Competitive scenario
    • 7.7.5.3. Regulatory framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. Spain market estimates and forecasts, 2018 - 2030
  • 7.7.6. Denmark
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Competitive scenario
    • 7.7.6.3. Regulatory framework
    • 7.7.6.4. Reimbursement scenario
    • 7.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
  • 7.7.7. Sweden
    • 7.7.7.1. Key country dynamics
    • 7.7.7.2. Competitive scenario
    • 7.7.7.3. Regulatory framework
    • 7.7.7.4. Reimbursement scenario
    • 7.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
  • 7.7.8. Norway
    • 7.7.8.1. Key country dynamics
    • 7.7.8.2. Competitive scenario
    • 7.7.8.3. Regulatory framework
    • 7.7.8.4. Reimbursement scenario
    • 7.7.8.5. Norway market estimates and forecasts, 2018 - 2030
• 7.8. Asia Pacific
  • 7.8.1. Japan
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Competitive scenario
    • 7.8.1.3. Regulatory framework
    • 7.8.1.4. Reimbursement scenario
    • 7.8.1.5. Japan market estimates and forecasts, 2018 - 2030
  • 7.8.2. India
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Competitive scenario
    • 7.8.2.3. Regulatory framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. India market estimates and forecasts, 2018 - 2030
  • 7.8.3. China
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Competitive scenario
    • 7.8.3.3. Regulatory framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. China market estimates and forecasts, 2018 - 2030
  • 7.8.4. South Korea
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Competitive scenario
    • 7.8.4.3. Regulatory framework
    • 7.8.4.4. Reimbursement scenario
    • 7.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
  • 7.8.5. Australia
    • 7.8.5.1. Key country dynamics
    • 7.8.5.2. Competitive scenario
    • 7.8.5.3. Regulatory framework
    • 7.8.5.4. Reimbursement scenario
    • 7.8.5.5. Australia market estimates and forecasts, 2018 - 2030
  • 7.8.6. Thailand
    • 7.8.6.1. Key country dynamics
    • 7.8.6.2. Competitive scenario
    • 7.8.6.3. Regulatory framework
    • 7.8.6.4. Reimbursement scenario
    • 7.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
• 7.9. Latin America
  • 7.9.1. Brazil
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Competitive scenario
    • 7.9.1.3. Regulatory framework
    • 7.9.1.4. Reimbursement scenario
    • 7.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
  • 7.9.2. Mexico
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Competitive scenario
    • 7.9.2.3. Regulatory framework
    • 7.9.2.4. Reimbursement scenario
    • 7.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
  • 7.9.3. Argentina
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Competitive scenario
    • 7.9.3.3. Regulatory framework
    • 7.9.3.4. Reimbursement scenario
    • 7.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
• 7.10. MEA
  • 7.10.1. South Africa
    • 7.10.1.1. Key country dynamics
    • 7.10.1.2. Competitive scenario
    • 7.10.1.3. Regulatory framework
    • 7.10.1.4. Reimbursement scenario
    • 7.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
  • 7.10.2. Saudi Arabia
    • 7.10.2.1. Key country dynamics
    • 7.10.2.2. Competitive scenario
    • 7.10.2.3. Regulatory framework
    • 7.10.2.4. Reimbursement scenario
    • 7.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
  • 7.10.3. UAE
    • 7.10.3.1. Key country dynamics
    • 7.10.3.2. Competitive scenario
    • 7.10.3.3. Regulatory framework
    • 7.10.3.4. Reimbursement scenario
    • 7.10.3.5. UAE market estimates and forecasts, 2018 - 2030
  • 7.10.4. Kuwait
    • 7.10.4.1. Key country dynamics
    • 7.10.4.2. Competitive scenario
    • 7.10.4.3. Regulatory framework
    • 7.10.4.4. Reimbursement scenario
    • 7.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
  • 8.2.1. Innovators
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2023
  • 8.3.4. BD
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Baxter
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. B. Braun SE
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Medtronic
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Fresenius Medical Care AG
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. DaVita
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Asahi Kasei Medical Co., Ltd.
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Nipro Corp.
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. Nikkiso Co., Ltd.
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. Cantel Medical
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives

관련자료